top of page

NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV

Product details

Registration number: SIN17148P

Classification: Prescription Only

Active ingredients: SARS-CoV-2 recombinant spike protein (Omicron JN.1)

Strength: 5 mcg/dose

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

ATC code: J07BN04

HSA approval date: 16 December 2024

Manufacturer(s): Siegfried Hameln GmbH

Manufacturing country/countries: GERMANY

What are the HSA registration number and classification for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17148P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?

According to the HSA dataset updated 7 August 2026:

Active ingredients: SARS-CoV-2 recombinant spike protein (Omicron JN.1)

Strength: 5 mcg/dose

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?

According to the HSA dataset updated 7 August 2026:

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Siegfried Hameln GmbH

Manufacturing country/countries: GERMANY

Source for this answer

Where can I look up NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17148P or the exact product name NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV. The general register link does not preselect this product.

Source for this answer

What are the source dates for this NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17148P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page